Related Experiment Video
Updated: Dec 12, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
Hospital Diabetes Meeting 2020
Guillermo Umpierrez1, Robert Rushakoff2, Jane Jeffrie Seley3
1Emory University, Atlanta, GA, USA.
Journal of Diabetes Science and Technology
|August 14, 2020
Summary
Hospitalized patients with diabetes face risks from poor glycemic control. This virtual meeting highlighted new technologies and strategies for managing diabetes in hospitals, especially during the COVID-19 pandemic.
Area of Science:
- Endocrinology
- Medical Informatics
- Public Health
Background:
- Hospitalized patients with diabetes are at risk for adverse glycemic control outcomes.
- Advancements in medical technology, including continuous glucose monitoring and insulin-dosing software, offer potential improvements in inpatient diabetes care.
- New strategies are required to integrate these evolving treatments into routine hospital practices.
Framework:
- The Diabetes Technology Society convened a virtual meeting on April 24-25, 2020, focusing on hospital diabetes management.
- The meeting was adapted to a virtual format due to the COVID-19 pandemic, ensuring participant safety and continuity of care for COVID-19 patients.
- Ten key sessions covered inpatient management, diabetic emergencies, insulin dosing technology, COVID-19 and diabetes, hypoglycemia, data security, and quality/safety.
Implementation:
- The virtual format facilitated the dissemination of current research and practices to healthcare professionals nationwide.
- Discussions emphasized the integration of technology into diabetes management within hospital settings.
- The meeting provided a platform for education on managing diabetes during a global health crisis.
Implications:
- This report summarizes critical updates on managing diabetes in hospitalized patients, incorporating technological advancements.
- The findings are crucial for healthcare professionals seeking to optimize glycemic control and patient outcomes in inpatient settings.
- The meeting's focus on technology and safety underscores the evolving landscape of diabetes care, particularly in the context of pandemics.
More Related Videos
Related Concept Videos
Diabetes: Management and Pharmacotherapy
766
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
766
Diabetes Mellitus: Type 2 and Gestational
4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes: Symptoms, Diagnosis, and Complications
1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Hypoglycemia and Glucagon
674
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
674
Pathophysiology of Diabetes
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K

